Drug Profile
Hib-DTP vaccine (Easyfour) - Panacea Biotec
Alternative Names: DTwP-Hib vaccine - Panacea Biotec; Easy-4; Easyfour; Easyfour - Chiron Panacea; Easyfour-TT; Quadrivalent vaccine - Panacea BiotecLatest Information Update: 15 Nov 2019
Price :
$50
*
At a glance
- Originator Panacea Biotec
- Class Bacterial vaccines; Conjugate vaccines; Haemophilus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diphtheria; Haemophilus infections; Pertussis; Tetanus
Most Recent Events
- 15 Nov 2019 Panacea Biotec completes a phase III trial for Diphtheria, Haemophilus infections, Pertussis and Tetanus in India before November 2019 (CTRI2014-12-005326)
- 01 Jan 2008 Launched for Diphtheria, Tetanus, Pertussis and Haemophilus infections (prevention) in India (IM)